Last CNY27.11 CNY
Change Today 0.00 / 0.00%
Volume 0.0
600332 On Other Exchanges
Symbol
Exchange
600332 is not on other exchanges.
As of 2:05 AM 12/3/14 All times are local (Market data is delayed by at least 15 minutes).

guangzhou baiyunshan phar-a (600332) Snapshot

Open
CNY27.00
Previous Close
CNY27.11
Day High
CNY27.44
Day Low
CNY26.64
52 Week High
02/12/14 - CNY30.05
52 Week Low
04/28/14 - CNY22.23
Market Cap
33.2B
Average Volume 10 Days
0.0
EPS TTM
CNY0.83
Shares Outstanding
1.1B
EX-Date
07/30/14
P/E TM
32.8x
Dividend
CNY0.23
Dividend Yield
1.07%
Current Stock Chart for GUANGZHOU BAIYUNSHAN PHAR-A (600332)

Related News

No related news articles were found.

guangzhou baiyunshan phar-a (600332) Related Businessweek News

No Related Businessweek News Found

guangzhou baiyunshan phar-a (600332) Details

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is engaged in the research, development, manufacture, and sale of Chinese patent medicines (CPM) and health products primarily in the People’s Republic of China. It is also involved in the production and sale of prepackaging food, dairy products, etc; sale of Chinese herbal medicines; wholesale and retail of western pharmaceutical products, medical apparatus, CPM, and Chinese raw medicines; and wholesale of goods other than pharmaceutical products. As of December 31, 2013, the company had 36 retail chain pharmacy outlets, including 35 outlets under the Cai Zhi Lin name and 1 pharmacy under the Ying Bang name. It also exports its products. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. The company was founded in 1997 and is headquartered in Guangzhou, the People’s Republic of China. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is a subsidiary of Guangzhou Pharmaceutical Holdings Limited.

11,284 Employees
Last Reported Date: 03/17/14
Founded in 1997

guangzhou baiyunshan phar-a (600332) Top Compensated Officers

General Manager, Executive Director and Membe...
Total Annual Compensation: CNY1.1M
Chairman and Chairman of Strategic Developmen...
Total Annual Compensation: --
Executive Director and Member of Budget Commi...
Total Annual Compensation: --
Supervisor
Total Annual Compensation: CNY709.0K
Compensation as of Fiscal Year 2013.

guangzhou baiyunshan phar-a (600332) Key Developments

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, Board Meeting, Dec 24, 2014

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, Board Meeting, Dec 24, 2014. Agenda: To discuss and approve the proposal of postponement of resumption of its shares.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Unaudited Consolidated and Standalone Earnings Results for the Third Quarter and Year to Date Ended September 30, 2014

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited reported unaudited consolidated and standalone earnings results for the third quarter and year to date ended September 30, 2014. For the quarter, the company reported consolidated income from operations of RMB 4,615,051,851.34 compared to RMB 4,132,348,626.80 a year ago. Operating profit was RMB 235,183,564.48 compared to RMB 167,752,361.19 a year ago. Total profit was RMB 239,751,486.77 compared to RMB 176,495,745.56 a year ago. Net profit was RMB 175,998,950.45 compared to RMB 146,716,799.62 a year ago. Net profit attributable to the shareholders of the Company was RMB 183,183,166.77 compared to RMB 141,028,901.05 a year ago. Basic and diluted earnings per share were RMB 0.142 compared to RMB 0.111 a year ago. For the year to date, the company reported consolidated income from operations of RMB 14,635,342,188.97 compared to RMB 13,204,821,420.31 a year ago. Operating profit was RMB 1,075,195,253.25 compared to RMB 848,518,077.97 a year ago. Total profit was RMB 1,095,723,098.66 compared to RMB 866,555,471.49 a year ago. Net profit was RMB 873,651,767.60 compared to RMB 753,119,235.27 a year ago. Net profit attributable to the shareholders of the Company was RMB 856,842,320.62 compared to RMB 728,258,336.93 a year ago. Basic and diluted earnings per share were RMB 0.6664 compared to RMB 0.573 a year ago. Net cash flows from operating activities were RMB 1,860,186,671.69 compared to RMB 1,287,916,683.34 a year ago. For the quarter, the company reported standalone income from operations of RMB 664,631,436.73 compared to RMB 751,777,291.55 a year ago. Operating profit was RMB 134,061,213.05 compared to RMB 88,920,864.48 a year ago. Total profit was RMB 133,452,908.18 compared to RMB 89,071,176.03 a year ago. Net profit was RMB 108,265,709.77 compared to RMB 79,211,782.24 a year ago. For the year to date, the company reported standalone income from operations of RMB 2,259,126,890.71 compared to RMB 1,047,380,378.80 a year ago. Operating profit was RMB 751,365,261.00 compared to RMB 391,700,030.81 a year ago. Total profit was RMB 751,110,711.25 compared to RMB 391,750,821.72 a year ago. Net profit was RMB 666,359,108.76 compared to RMB 367,265,214.38 a year ago. Net cash flows from operating activities were RMB 226,871,368.43 compared to RMB 129,401,769.95 a year ago.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, Board Meeting, Oct 29, 2014

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, Board Meeting, Oct 29, 2014. Agenda: To discuss and approve the proposal of the third quarter report of 2014; to consider the proposal of changing its accounting policy; to approve the proposal of agreeing to authorize Executive Director Wu Changhai, Head of Financial Department Yao Zhizhi; and to consider legal representative to sign the third quarter report of 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600332:CH CNY27.11 CNY 0.00

600332 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600332.
View Industry Companies
 

Industry Analysis

600332

Industry Average

Valuation 600332 Industry Range
Price/Earnings 31.5x
Price/Sales 1.8x
Price/Book 4.7x
Price/Cash Flow 25.9x
TEV/Sales 1.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GUANGZHOU BAIYUNSHAN PHAR-A, please visit www.gpc.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.